- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.09. | J&J sweetens controversial talc settlement deal | ||
| 05.09. | Advanz wins stay on EU revocation of Ocaliva license | ||
| 05.09. | Trial of Click's DTx for migraine sets up FDA filing | ||
| 05.09. | ArsenalBio raises $325m for programmable CAR-T platform | ||
| 05.09. | Lilly to hunt non-coding DNA for obesity drugs in $1bn deal | ||
| 04.09. | Novartis' oral PNH drug Fabhalta rolls out in England, Wales | ||
| 04.09. | Roche trumpets new fenebrutinib data in relapsing MS | ||
| 04.09. | Regeneron joins Koneksa Parkinson's digital biomarker study | ||
| 04.09. | Illumina avoids hefty EU fine over Grail merger | ||
| 04.09. | Vaxcyte's pneumococcal vaccine win points to Prevnar battle | ||
| 03.09. | Advanz Pharma's bid to keep Ocaliva on EU market fails | ||
| 03.09. | 3D-printed tumours could aid cancer therapy R&D | ||
| 03.09. | Data builds behind Valneva, Pfizer's Lyme disease vaccine | ||
| 03.09. | Digital NHS health checks will start in England next year | ||
| 03.09. | As mpox cases rise over 18,000, UNICEF tenders for vaccines | ||
| 02.09. | BIA sends message to UK chancellor on R&D tax credits | ||
| 02.09. | iRhythm wearable heart monitor raises AFib diagnoses by 52% | ||
| 02.09. | Two of three trials fail, but Sanofi will still file MS drug | ||
| 02.09. | Kerendia works in heart failure, but how might it be used? | ||
| 30.08. | Emergent Bio gets FDA green light for mpox vaccine | ||
| 30.08. | UK biotech ReNeuron quits AIM as financing push fails | ||
| 30.08. | BioMarin's change in direction claims more jobs | ||
| 30.08. | J&J launches gMG market bid with nipocalimab filing | ||
| 30.08. | Bayer takes lung cancer therapy hope into phase 3 | ||
| 29.08. | GSK gets EU okay for RSV shot in younger age group |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
